Key Market Indicators
Sales of Latvian beta blockers are set to reach $8.6 million by 2026. In 2021, the market was valued at $8.4 million, representing a 0.6% year-on-year growth. Since 2006, the country has seen a 0.8% annual decline. Last year, it ranked 21st in the world, with Slovenia ranking higher at $8.4 million. Italy, Canada, and Australia ranked 2nd, 3rd, and 4th respectively.
